Darma Henwa Tbk vs Merck Tbk. — how do they compare? Darma Henwa Tbk trades at Rp366 (market cap 14.73T, 224.99M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Darma Henwa Tbk is far larger — about 8.7× Merck Tbk.'s market cap, and Darma Henwa Tbk is more actively traded (224.99M versus 21.9K). Which is the better fit depends on your goals.
| DEWA | MERK | |
|---|---|---|
Market Cap | 14.73T | 1.7T |
Volume | 224.99M | 21.9K |
Lot | 2.25M | 219 |
Turnover | 81.41B | 83.99M |
Average Price | 361.83 | 3,834.93 |
Value | 81.41B | 83.99M |
Indicative Equilibrium Price | 362 | 3,850 |
Indicative Equilibrium Volume | 1.86M | 1 |
Trailing returns across standard periods
Latest headlines on both assets
Darma Henwa Tbk (the Company) was established on 8 Oct 1991 based on Notaries Deed No.54, then changed to PT HWE Indonesia on Jan 2005. The Company started its commercial operations on 1993 with early main bussines in mining, and machine and equipment leasing. At Sep 5, 2005 company's name changed to PT Darma Henwa.
Read more on DEWA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →